SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery

Biomaterials

Volumn 34, Issue 14, 2013, Pages 3706-3715

  Fan, Ching Hsiang ^a   Ting, Chien Yu ^a   Lin, Han Jung ^a   Wang, Chung Hsin ^a   Liu, Hao Li ^b   Yen, Tzu Chen ^b   Yeh, Chih Kuang ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Blood brain barrier; Focused ultrasound; Glioblastoma; Microbubbles; Superparamagnetic iron oxide

Indexed keywords

BLOOD-BRAIN BARRIER; FOCUSED ULTRASOUND; GLIOBLASTOMAS; MICROBUBBLES; SUPERPARAMAGNETIC IRON OXIDES;

BLOOD; DEPOSITION; IRON OXIDES; MAGNETIC RESONANCE IMAGING; SUPERPARAMAGNETISM; TUMORS; ULTRASONICS;

DRUG DELIVERY;

CONTRAST MEDIUM; DOXORUBICIN; SUPERPARAMAGNETIC IRON OXIDE;

ACOUSTIC ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GLIOMA; HUMAN; HUMAN CELL; MALE; MICROBUBBLE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCALP; ULTRASOUND;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; MAGNETIC RESONANCE IMAGING; MALE; MICROBUBBLES; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 84875279479     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.099     Document Type: Article

References (35)

1. Wen P.Y., Kesari S. Malignant gliomas in adults. N Engl J Med 2008, 359:492-507.
2. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114:97-109.
3. Aoki T., Hashimoto N., Matsutani M. Management of glioblastoma. Expert Opin Pharmacother 2007, 8:3133-3146.
4. Maher E.A., Mietz J., Arteaga C.L., DePinho R.A., Mohla S. Research brain metastasis: opportunities in basic and translational research. Cancer Res 2009, 69:6015-6020.
5. Krex D., Klink B., Hartmann C., von Deimling A., Pietsch T., Simon M., et al. Long-term survival with glioblastoma multiforme. Brain 2007, 130:2596-2606.
6. Walter K.A., Tamargo R.J., Olivi A., Burger P.C., Brem H. Intratumoral chemotherapy. Neurosurgery 1995, 37:1129-1145.
7. Yang F.Y., Teng M.C., Lu M., Liang H.F., Lee Y.R., Yen C.C., et al. Treating glioblastomamultiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound. Int J Nanomedicine 2012, 7:965-974.
8. Muldoon L.L., Soussain C., Jahnke K., Johanson C., Siegal T., Smith Q.R., et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol 2007, 25:2295-2305.
9. Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles. Drug Discov Today 2008, 13:1099-1106.
10. Sheikov N., McDannold N., Sharma S., Hynynen K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 2008, 34:1093-1104.
11. Andersen C., Taagehøj J.F., Mühler A., Rehling M. Approximation of arterial input curve data in MRI estimation of cerebral blood-tumor-barrier leakage: comparison between Gd-DTPA and 99mTc-DTPA input curves. Magn Reson Imaging 1996, 14:235-241.
12. Hynynen K., McDannold N., Vykhodtseva N., Jolesz F.A. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001, 220:640-646.
13. Hynynen K., McDannold N., Sheikov N.A., Jolesz F.A., Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 2005, 24:12-20.
14. Treat L.H., McDannold N., Vykhodtseva N., Zhang Y., Tam K., Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007, 121:901-907.
15. Park J., Zhang Y., Vykhodtseva N., Jolesz F.A., McDannold N.J. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. J Control Release 2012, 162:134-142.
16. Jalali S., Huang Y., Dumont D.J., Hynynen K. Focused ultrasound-mediated bbb disruption is associated with an increase in activation of AKT: experimental study in rats. BMC Neurol 2010, 10:114.
17. Raymond S.B., Skoch J., Hynynen K., Bacskai B.J. Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo. J Cereb Blood Flow Metab 2007, 27:393-403.
18. Sheikov N., McDannold N., Vykhodtseva N., Jolesz F., Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 2004, 30:979-989.
19. Feshitan J.A., Vlachos F., Sirsi S.R., Konofagou E.E., Borden M.A. TheranosticGd(III)-lipid microbubbles for MRI-guided focused ultrasound surgery. Biomaterials 2012, 33:247-255.
20. Veiseh O., Gunn J.W., Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010, 62:284-304.
21. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 21:2133-2148.
22. Liu H.L., Hsu P.H., Chu P.C., Wai Y.Y., Chen J.C., Shen C.R., et al. Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles: usefulness for distinguishing between focused ultrasound-induced blood-brain barrier disruption and brain hemorrhage. J Magn Reson Imaging 2009, 29:31-38.
23. Ting C.Y., Fan C.H., Liu H.L., Huang C.Y., Hsieh H.Y., Yen T.C., et al. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 2012, 33:704-712.
24. Liu Z., Lammers T., Ehling J., Fokong S., Bornemann J., Kiessling F., et al. Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 2011, 32:6155-6163.
25. Lentacker I., Geers B., Demeester J., De Smedt S.C., Sanders N.N. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther 2010, 18:101-108.
26. Tinkov S., Coester C., Serba S., Geis N.A., Katus H.A., Winter G., et al. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J Control Release 2010, 148:368-372.
27. Liu H.L., Hua M.Y., Yang H.W., Huang C.Y., Chu P.C., Wu J.S., et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A 2010, 107:15205-15210.
28. Corot C., Robert P., Idée J.M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006, 58:1471-1504.
29. Liu H.L., Wai Y.Y., Hsu P.H., Lyu L.A., Wu J.S., Shen C.R., et al. In vivo assessment of macrophage CNS infiltration during disruption of the blood-brain barrier with focused ultrasound: a magnetic resonance imaging study. J Cereb Blood Flow Metab 2010, 30:177-186.
30. Liu HL, Chen PY, Yang HW, Wu JS, Tseng IC, Ma YJ, et al. In vivo MR quantification of superparamagnetic iron oxide nanoparticle leakage during low-frequency-ultrasound-induced blood-brain barrier opening in swine. J Magn Reson Imaging 2011;34:1313-1324.
31. Chertok B., David A.E., Huang Y., Yang V.C. Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics. J Control Release 2007, 122:315-323.
32. Chertok B., Moffat B.A., David A.E., Yu F., Bergemann C., Ross B.D., et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 2008, 29:487-496.
33. Corot C., Petry K.G., Trivedi R., Saleh A., Jonkmanns C., Le Bas J.F., et al. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmallsuperparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 2004, 39:619-625.
34. Dousset V., Delalande C., Ballarino L., Quesson B., Seilhan D., Coussemacq M., et al. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 1999, 41:329-333.
35. Rausch M., Hiestand P., Baumann D., Cannet C., Rudin M. MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med 2003, 50:309-314.